CI - Cigna Corporation
| Previous Close | 193.56 |
| Open | 193.91 |
| Bid | 189.54 x 800 |
| Ask | 191.59 x 800 |
| Day's Range | 188.80 - 194.96 |
| 52 Week Range | 141.95 - 211.58 |
| Volume | 1993334 |
| Avg. Volume | 2,023,250 |
| Market Cap | 71B |
| Beta (5Y Monthly) | 0.75 |
| PE Ratio (TTM) | 15.63 |
| EPS (TTM) | 12.15 |
| Earnings Date | Feb 6, 2020 |
| Forward Dividend & Yield | 0.04 (0.02%) |
| Ex-Dividend Date | 2019-03-08 |
| 1y Target Est | 219.27 |
- Zacks
Cigna Considers Divesting Its Non-Health Insurance Business
Speculations ran rife that Cigna (CI) is on the lookout of a bidder for its non-health insurance arm to streamline in-house operations.
- Bloomberg
Nothing Measured, Nothing Gained
(Bloomberg Opinion) -- Measurement can be a remarkably effective tool for social change. When a new round of international student assessments was released last week, South Korea, Singapore and Finland received plaudits for their strong performance. There was relief in Sweden at its recovery from its earlier fall in the ratings. And the Philippines was put on notice that its performance is unacceptable.In similar fashion, the World Bank’s Doing Business Index gives countries an incentive to streamline their regulations, while Transparency International’s Corruption Perceptions Index does the same for countries tackling that problem.These successes raise a question: Which other indexes might be useful? Think of the suggestions that follow as a kind of Christmas wish list.How about a loneliness index? David Brooks has argued that America faces a crisis of loneliness, making us unhappy and impoverishing us spiritually. I find these claims plausible, especially since the median U.S. household size has been shrinking.Still, just how bad is this problem? One recent study found that American loneliness has not been rising lately, and that loneliness increases only after people reach their early 70s. On the other hand, Cigna’s “loneliness survey” of 20,000 Americans aged 18 and over, published earlier this year, found the youngest Americans to be the most lonely, and the oldest ones the least.But Cigna’s study relies too much on online self-reporting. It is possible to measure interactions with other people, as well as civic engagement. A greater effort to systematize the data would be helpful.A stress index for Americans another related idea: Just how much do our lives focus our attention on our worries rather than on our joys and hopeful expectations?There are less emotional concerns as well. How about an infrastructure speed index? I worry about bureaucratization and the slow pace of building important public works. Construction on Manhattan’s Second Avenue subway line, for example, started in 1972, paused, resumed in 2004, and was finally completed (the first phase, anyway) in 2017. In contrast, construction of the core New York City subway system, with 28 stations, began in 1900 and finished in 1904. Similarly, construction of the Empire State Building took only 410 days.Why do so many U.S. infrastructure projects today take so long? And if the process of improving and reshaping the environment to further human progress is now so much slower, doesn’t it make sense to try to measure this decline for the purpose of eventual improvement? Given the need for a greener energy infrastructure, this is a matter of the utmost urgency.Speaking of energy infrastructure, how about a severity index for climate change and associated problems? In general, estimates of the cost of climate change have been rising, and some now run as high as 10% of GDP by 2100. New data suggests that permafrost melting in the Arctic and Greenland is further along than many observers had been expecting, and they say this change could release further carbon into the atmosphere.That sounds bad. But exactly how bad? I am a relatively numerate, well-educated professor of economics, and I don’t know. I understand this would be one of the less exact indexes under consideration, and it would be especially important to keep it out of politicized hands. Still, it could help make vivid the dilemmas we face.There should also be an innovation index to measure the positive impact of American ingenuity. The U.S. is the world leader in Nobel laureates, startup businesses, tech companies, medical innovations and many other areas of economic progress. In a given year, just how much does the rest of the world benefit from U.S. creativity? Calls for the U.S. to adopt the supposedly superior systems of Western European countries, for instance in health care, are common. That’s a debate worth having, but it requires good data. One piece of information worth knowing is just how much good the U.S. is doing for the rest of the world under the current system.There is a new international index of how well countries respond to the sexual abuse and exploitation of children, and the U.S. ranks highly. That’s certainly good to see, but how about an index measuring violence against children in the U.S., perhaps on a state-by-state or city-by-city basis? It would help show which state and local governments were best addressing these issues.Indexes are informative, easy to digest, and remarkably well-suited for social-media sharing. At their best, they can actually be fun. Creating more of them is one way social scientists can satisfy the growing public hunger for knowledge and accountability.To contact the author of this story: Tyler Cowen at tcowen2@bloomberg.netTo contact the editor responsible for this story: Michael Newman at mnewman43@bloomberg.netThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Tyler Cowen is a Bloomberg Opinion columnist. He is a professor of economics at George Mason University and writes for the blog Marginal Revolution. His books include "Big Business: A Love Letter to an American Anti-Hero."For more articles like this, please visit us at bloomberg.com/opinion©2019 Bloomberg L.P.
- Kiplinger
15 Large-Cap Stocks Betting Big on Mamp;A
The right mergers and acquisitions (M&A;) can make a good company even better by opening up new markets, expanding capabilities and market share, and diversifying product lines.Not every deal is a guaranteed winner, but investors typically benefit from smart M&A.; A 2016 Booth Business School study found, on average, an increase in overall value for both the acquiring and acquired companies at the time of the merger, and a long-term rise in value for companies that made cash acquisitions.Consider the $81 billion merger between Exxon and Mobil in 1999 that created Exxon Mobil (XOM) - now a $300 billion goliath and the largest publicly traded energy company on U.S. exchanges. Or there's Walt Disney's (DIS) $6 billion buyout of Pixar in 2006. The studio's animated films have generated nearly $11 billion in worldwide box office alone, not accounting for merchandise and other related opportunities.Last year was an especially good year for corporate M&A; thanks to major catalysts provided by tax reform, low borrowing costs and a healthy stock market. Dealmaking hit near-record levels last year. According to Mergermarket, 5,718 transactions closed, and deal volume exceeded $1.5 trillion - the second-highest total ever. Also noteworthy was last year's surge in "mega-deals" - transactions valued at more than $10 billion. These included Keurig Dr. Pepper's (KDP) $27 billion acquisition of soft drink maker Dr. Pepper Snapple Group and pharmacy chain CVS Health's (CVS) $70 billion takeover of health insurance provider Aetna.Here are 15 large-cap stocks that are looking for big things out of their pending or recently closed M&A; deals. These mergers and acquisitions are either already sparking new life in the acquiring companies, or analysts and other market professionals expect them to do so over the coming years. SEE ALSO: The Berkshire Hathaway Portfolio: All 47 Buffett Stocks Explained
- American City Business Journals
New York Life in talks with Cigna to buy nonhealth benefits unit
New York Life Insurance Co. is negotiating with Cigna Corp. to buy a unit that sells non-medical insurance products to employers in a deal that could be worth as much as $6 billion.
- Zacks
UnitedHealth (UNH) to Buy Diplomat, Expand Pharmacy Services
UnitedHealth (UNH) inks an agreement to acquire Diplomat to expand its in-house pharmacy benefit management business.
- MarketWatch
These companies have low labor costs that can turn into a stock payday for you
DEEP DIVE One of the best aspects of the slow but sustained growth of the U.S. economy has been that hourly wages have been growing faster than the overall economy. This is wonderful for consumers. But with slow growth overall, the tight labor market can put a damper on corporate profits and hurt investors’ returns.
- Simply Wall St.
Insider Buying: The Cigna Corporation (NYSE:CI) Independent Director Just Bought US$2.0m Worth Of Shares
Those following along with Cigna Corporation (NYSE:CI) will no doubt be intrigued by the recent purchase of shares by...
- Financial Times
New York Life in talks to buy Cigna unit for nearly $6bn
New York Life Insurance is in advanced talks to acquire a Cigna unit that sells nonmedical insurance coverage to employers for nearly $6bn, according to multiple people briefed on the negotiations. The deal would bolster New York Life as it seeks to broaden its business beyond its core life insurance and annuities franchises, units that have come under pressure from a slide in interest rates and intense competition from rivals. New York Life had emerged as the frontrunner over MetLife and Sun Life Financial in the auction for the Cigna unit, which sells accident, disability and life insurance plans to companies to offer to their employees, the people said.
- GuruFocus.com
Top Insider Buys Highlight for the Week of Dec. 6
Insiders invest in Cigna, Dollar Tree, Keurig Dr Pepper and Expedia Continue reading...
- Zacks
Here's Why Select Medical (SEM) Stock Looks Attractive
Select Medical (SEM) benefits from revenue growth, acquisitions, and strong earnings guidance.
- Zacks
UnitedHealth (UNH) Provides Guidance for 2020, Shares Fall
UnitedHealth's (UNH) guidance for 2020 indicates revenue and earnings growth but it is believed to be conservative, leading to a decline in shares.
- Simply Wall St.
Based On Its ROE, Is Cigna Corporation (NYSE:CI) A High Quality Stock?
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
- Insider Monkey
Did Hedge Funds Drop The Ball On CIGNA Corporation (CI)?
Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by more than 10 percentage points since the end of the third quarter of 2018 as investors first worried over the possible ramifications of rising interest rates and the escalation of the trade war with China. The hedge funds and institutional investors we track […]
- Zacks
BioDelivery's Belbuca Sales & Symproic Addition Encouraging
BioDelivery's (BDSI) efforts to increase preferred coverage for Belbuca and the acquisition of the rights to Symproic are likely to help continue its momentum.
- Zacks
Is Cigna Corporation (CI) a Solid Value Investor Pick Now?
Let's see if Cigna Corporation (CI) stock is a good choice for value-oriented investors right now from multiple angles.
- Business Wire
Cigna and the Cigna Foundation Help Improve Health and Well-being of Unpaid Family Caregivers in Massachusetts
Global health service company Cigna and the Cigna Foundation will offer a total of $50,000 in funding to help advance the work of non-profit organizations in Massachusetts that support the health and well-being of unpaid family caregivers. In Massachusetts, 840,000 individuals are unpaid caregivers1; and, as the population continues to age, that number is expected to rise significantly.
- Zacks
3 Healthcare Stocks to Counter Tech Encroachment
Traditional U.S. healthcare companies are resorting to vertical integration to counter the tech threat.
- Yahoo Finance
NBA legend Magic Johnson's biggest investing regret
Yahoo Finance speaks with NBA Hall of Famer and businessman Magic Johnson.
- Barrons.com
United Health and Cigna Stocks Are Rising Because the Medicare-for-All Threat Has Diminished
Political developments over the weekend seemed to lessen the chances of Medicare for All being implemented in the near term.
- American City Business Journals
Special Report: These are Denver's Most Admired CEOs for 2019
Twenty top executives were honored Nov. 14 at the Ritz Carlton, with a rock-star theme. Here's who they are, what they do and what they have to say.
- American City Business Journals
Most Admired CEO John Roble is growing market revenue as he leads one of region's largest health plans
At 40, the Cigna Mountain States regional leader is growing market revenue to $2 billion while keeping medical costs lower than other competitors in the market.
- Thomson Reuters StreetEvents
Edited Transcript of CI.N earnings conference call or presentation 31-Oct-19 12:30pm GMT
Q3 2019 Cigna Corp Earnings Call
- Moody's
Express Scripts Holding Company -- Moody's withdraws ratings on Express Scripts and Medco
Express Scripts is a subsidiary of Cigna Corporation ("Cigna"). The majority of the debt of Express Scripts and Medco has been exchanged into direct obligations of Cigna through a recently completed exchange offer.
- Morningstar
Checkup for Healthcare Moats
All of these companies now have narrow moats and stable moat trends. The U.S. health system continues to put significant financial pressure on many U.S. citizens, and we think medical insurers and pharmacy benefit managers will remain key targets of regulators looking to improve the U.S. healthcare system.
